Effective Collaboration - Team Research for Better Returns: Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Effective Collaboration - Team Research for Better Returns:

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

robert b furman

To: The Ox who wrote (5514)	2/15/2018 4:56:35 PM
From: Return to Sender	1 Recommendation of 8239

Just so you know Ox. I use your work to my advantage as well. I bought some TEVA on the cheap a while back. Years ago I watched TARO, another generic drug maker who was struggling at the time, flounder as a stock. TARO languished below 10 for the longest time if I remember correctly because there were concerns about their manufacturing from the FDA. They cleaned up their act. The chart below tells the tale: TEVA of course has problems of its own. That said I think in the long run the stock will do fine. Not as well as TARO might have done for me. That said, no one is talking me out of holding long term: Thanks, for sharing your thoughts here Ox. You can use my charts any time and anywhere you like! ;-) RtS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next